The global dry eye products market is witnessing steady expansion as rising screen exposure, aging populations, environmental stressors, and growing awareness of ocular health continue to increase demand for effective dry eye management solutions. Advancements in ophthalmic formulations and expanding access to eye care products are further strengthening the market outlook worldwide.
The dry eye products market size is projected to grow from US$ 6.95 billion in 2023 to US$ 10.04 billion by 2031, recording a CAGR of 4.7% during 2023–2031.
According to The Insight Partners’ Dry Eye Products Market Report, sustained product innovation, increasing diagnosis rates of dry eye disease (DED), and rising adoption of over‑the‑counter (OTC) and prescription therapies are expected to drive market growth through the forecast period.
Download Sample PDF @ https://www.theinsightpartners.com/sample/TIPRE00012323
Market Overview
Dry eye disease is a multifactorial condition characterized by insufficient tear production or excessive tear evaporation, leading to ocular discomfort, vision disturbances, and inflammation of the ocular surface. The condition has become increasingly prevalent due to lifestyle factors, medical conditions, and aging demographics.
Dry eye products include artificial tears, anti‑inflammatory drugs, lubricating ointments, punctal plugs, and dietary supplements that help alleviate symptoms and improve tear film stability. With growing emphasis on preventive eye care and long‑term management, the market continues to evolve with improved and patient‑friendly solutions.
Key Market Drivers Supporting Growth
Rising Digital Screen Exposure
One of the most significant drivers of the dry eye products market is increased screen time across all age groups. Extensive use of smartphones, computers, tablets, and digital displays reduces blink rate, contributing to tear film instability and dry eye symptoms.
The rise of remote work, online education, and digital entertainment has substantially expanded the at‑risk population, driving sustained demand for artificial tears and lubricating eye drops.
Growing Aging Population
The aging global population plays a crucial role in dry eye market expansion. Tear production tends to decline with age, making older adults more susceptible to dry eye disease and related ocular conditions.
As life expectancy increases worldwide, demand for chronic dry eye management solutions in geriatric care settings and outpatient ophthalmology practices is expected to rise steadily.
Increasing Prevalence of Chronic and Autoimmune Disorders
Medical conditions such as diabetes, rheumatoid arthritis, Sjögren’s syndrome, and thyroid disease are closely associated with dry eye symptoms. The rising prevalence of these chronic and autoimmune disorders is significantly contributing to increased diagnosis and treatment of dry eye disease.
Additionally, long‑term use of certain medications, including antihistamines and antidepressants, further increases susceptibility, boosting product adoption.
Improved Diagnosis and Awareness
Growing awareness among patients and healthcare professionals regarding dry eye disease has improved diagnosis rates worldwide. Eye care practitioners are increasingly using advanced diagnostic tools to detect and classify dry eye conditions at earlier stages.
Educational campaigns and routine eye examinations are encouraging timely intervention, supporting demand for both prescription and OTC dry eye products.
Advancements in Product Formulation and Delivery
Continuous innovation in ophthalmic formulations is driving market growth. Newer products focus on longer‑lasting hydration, reduced preservatives, lipid‑based formulations, and improved ocular surface compatibility.
The introduction of preservative‑free drops, multi‑dose delivery systems, and combination therapies has improved patient compliance and expanded treatment options.
Market Segmentation Analysis
By Product Type
- Artificial tears
- Anti‑inflammatory drugs
- Lubricating ointments and gels
- Punctal plugs
- Omega‑3 supplements
Artificial tears dominate the market due to widespread OTC availability and frequent daily use.
By Dosage Form
- Eye drops
- Gels and ointments
- Capsules
Eye drops account for the largest share, offering convenience and rapid relief.
By Distribution Channel
- Hospital pharmacies
- Retail pharmacies
- Online pharmacies
Retail pharmacies lead due to accessibility, while online pharmacies are growing rapidly with increased digital healthcare adoption.
Get Full Copy @ https://www.theinsightpartners.com/buy/TIPRE00012323
Geographical Market Insights
North America
North America holds a substantial share of the dry eye products market, supported by high awareness levels, advanced ophthalmic care infrastructure, and widespread screen usage. The United States remains the largest contributor, driven by strong OTC and prescription product sales.
Europe
Europe represents a mature market characterized by well‑established healthcare systems and routine eye care practices. Aging populations and increasing diagnosis of ocular disorders are key growth drivers across the region.
Asia Pacific
Asia Pacific is expected to register the fastest growth during the forecast period. Factors such as rising digitalization, urban pollution, improving healthcare access, and expanding middle‑class populations are driving demand in countries including China, India, Japan, and South Korea.
Latin America and Middle East & Africa
These regions are experiencing gradual growth driven by increasing awareness of eye health, expanding retail pharmacy networks, and improving access to ophthalmic products.
Competitive Landscape and Top Market Players
The dry eye products market is competitive, with companies focusing on brand differentiation, product innovation, and geographic expansion.
Key Companies Operating in the Market Include:
- Alcon Inc.
- Johnson & Johnson Vision Care
- Bausch + Lomb
- AbbVie Inc.
- Novartis AG
- Santen Pharmaceutical Co., Ltd.
- Otsuka Pharmaceutical Co., Ltd.
- Sun Pharmaceutical Industries Ltd.
- Horus Pharma
- Ursapharm Arzneimittel GmbH
These players are investing in R&D, expanding OTC product portfolios, and launching advanced formulations to strengthen their market position.
Recent Market Developments
- Launch of preservative‑free and lipid‑based artificial tears
- Expansion of prescription anti‑inflammatory dry eye therapies
- Increased focus on digital eye strain solutions
- Strategic collaborations between pharmaceutical and eye care brands
These trends reflect the industry’s emphasis on innovation and patient‑centric care.
Market Opportunities Through 2031
Key growth opportunities include:
- Rising demand for digital eye strain management products
- Expansion in emerging markets with underserved eye care needs
- Development of long‑acting and personalized dry eye therapies
- Growth of online ophthalmic product distribution channels
Companies that focus on education, accessibility, and innovation are well positioned to capture future growth.
Future Outlook
With a CAGR of 4.7% from 2023 to 2031, the dry eye products market is positioned for stable and sustained growth. Increasing lifestyle‑related eye disorders, demographic shifts, and continued technological innovation will underpin long‑term market expansion.
Preventive eye care, early diagnosis, and improved treatment options are expected to further enhance product adoption across global markets.
Related Reports @
Diabetic Eye Disease Equipment Market Demand, Size & Forecast by 2034
Veterinary Eye Care Market Growth, Trends & Demand by 2034
Eye Examination Equipment Market Size, Share & Demand by 2034
Medical Eye Sponge Market Size, Demand & Growth by 2034
About Us –
The Insight Partners provides comprehensive syndicated and tailored market research services in the healthcare, technology, and industrial domains. Renowned for delivering strategic intelligence and practical insights, the firm empowers businesses to remain competitive in ever-evolving global markets.
Contact Us:
Contact Person: Ankit Mathur
E-mail: ankit.mathur@theinsightpartners.com
Phone: +1-646-491-9876
Also Available in : Korean German Japanese French Chinese Italian Spanish
